Search

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog approved by the FDA (as Egrifta) to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy. It is supported by phase 3 randomized controlled trials for that specific indication. It is a prescription medication and is not approved for general body-composition or anti-aging use.